These prodrugs showed selective uptake into the GLUT5-expressing MCF-7 breast cancer cell line compared with the 184B5 non-cancerous mammary tissue cell line, which competed with the uptake of previously used fluorescent probes, showing a GLUT5-dependent uptake mechanism. The gene discussed is SLC2A5; the disease is breast carcinoma.